Pharmaceutical Business review

Palatin Technologies revenues fall in Q4

The company has posted a net loss of $4.24m for the fourth quarter 2010, or $0.40 loss per diluted share, compared to net loss of $200,530, or $0.02loss per diluted share, for the comparable period in 2009.

For the full year ended 30 June 2010, the company has posted revenue of $14.18m for the 12 months, compared to $11.35m for the year ago period.

Palatin has reported a net loss of $1.79m, or $0.18 per diluted share, compared to $4.8m, or $0.56 loss per diluted share, for the year ago period.